Advertisement
AKTS vs SPRY
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKTS is a Hold and SPRY is a StrongBuy.
AKTS in downward trend: 10-day moving average crossed below 50-day moving average on September 16, 2026
The 10-day moving average for AKTS crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AKTS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for AKTS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
AKTS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 15 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.733) is normal, around the industry mean (2.978). P/E Ratio (-11.428) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (125.000) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. AKTS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 72 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AKTS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
SPRY's RSI Oscillator ascending out of oversold territory
The RSI Oscillator for SPRY moved out of oversold territory on September 28, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 34 similar instances when the indicator left oversold territory. In 28 of the 34 cases the stock moved higher. This puts the odds of a move higher at 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 43 of 55 cases where SPRY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Moving Average Convergence Divergence (MACD) for SPRY just turned positive on September 29, 2026. Looking at past instances where SPRY's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.
Following a +6.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where SPRY advanced for three days, in 233 of 285 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPRY as a result. In 79 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPRY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
The Aroon Indicator for SPRY entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. SPRY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (33.621) is normal, around the industry mean (2.978). P/E Ratio (-1.940) is within average values for comparable stocks, (-0.692). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (134.267) among similar stocks. P/S Ratio (3.535) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SPRY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
AKTS | SPRY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 51 | 14 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 15 Undervalued | 90 Overvalued | |
PROFIT vs RISK RATING 1..100 | 72 | 100 | |
SMR RATING 1..100 | 94 | 100 | |
PRICE GROWTH RATING 1..100 | 50 | 50 | |
P/E GROWTH RATING 1..100 | 14 | 15 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
AKTS's Valuation (15) in the Telecommunications Equipment industry is significantly better than the same rating for SPRY (90) in the null industry. This means that AKTS’s stock grew significantly faster than SPRY’s over the last 12 months.
AKTS's Profit vs Risk Rating (72) in the Telecommunications Equipment industry is in the same range as SPRY (100) in the null industry. This means that AKTS’s stock grew similarly to SPRY’s over the last 12 months.
AKTS's SMR Rating (94) in the Telecommunications Equipment industry is in the same range as SPRY (100) in the null industry. This means that AKTS’s stock grew similarly to SPRY’s over the last 12 months.
AKTS's Price Growth Rating (50) in the Telecommunications Equipment industry is in the same range as SPRY (50) in the null industry. This means that AKTS’s stock grew similarly to SPRY’s over the last 12 months.
AKTS's P/E Growth Rating (14) in the Telecommunications Equipment industry is in the same range as SPRY (15) in the null industry. This means that AKTS’s stock grew similarly to SPRY’s over the last 12 months.
| AKTS | SPRY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 81% | 2 days ago 82% |
| Stochastic ODDS (%) | N/A | 2 days ago 78% |
| Momentum ODDS (%) | N/A | 2 days ago 87% |
| MACD ODDS (%) | N/A | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 85% |
| Advances ODDS (%) | N/A | 13 days ago 82% |
| Declines ODDS (%) | 5 days ago 90% | 7 days ago 86% |
| BollingerBands ODDS (%) | 2 days ago 90% | N/A |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AKTS’s FA Score shows that 2 FA rating(s) are green while SPRY’s FA Score has 1 green FA rating(s).
- AKTS’s FA Score: 2 green, 3 red.
- SPRY’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AKTS’s TA Score shows that 2 TA indicator(s) are bullish while SPRY’s TA Score has 4 bullish TA indicator(s).
- AKTS’s TA Score: 2 bullish, 3 bearish.
- SPRY’s TA Score: 4 bullish, 3 bearish.
Price Growth
AKTS (@Biotechnology) experienced а -12.86% price change this week, while SPRY (@Biotechnology) price change was +1.20% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was +1.19%. For the same industry, the average monthly price growth was -15.14%, and the average quarterly price growth was -14.97%.
Reported Earning Dates
AKTS is expected to report earnings on Dec 02, 2026.
SPRY is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Biotechnology (+1.19% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
AKTS and
Correlation & Price change
A.I.dvisor tells us that AKTS and SPRY have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AKTS and SPRY's prices will move in lockstep.
| Ticker / NAME | Correlation To AKTS | 1D Price Change % | ||
|---|---|---|---|---|
| AKTS | 100% | +0.33% | ||
| SPRY - AKTS | 29% Poorly correlated | +5.22% | ||
| CRDO - AKTS | 24% Poorly correlated | +1.83% | ||
| KN - AKTS | 24% Poorly correlated | +3.40% | ||
| LITE - AKTS | 24% Poorly correlated | +1.26% | ||
| ZBRA - AKTS | 23% Poorly correlated | +1.83% | ||
More | ||||
SPRY and
Correlation & Price change
A.I.dvisor indicates that over the last year, SPRY has been loosely correlated with LPCN. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SPRY jumps, then LPCN could also see price increases.
| Ticker / NAME | Correlation To SPRY | 1D Price Change % | ||
|---|---|---|---|---|
| SPRY | 100% | +5.22% | ||
| LPCN - SPRY | 63% Loosely correlated | -1.92% | ||
| LXEO - SPRY | 41% Loosely correlated | +4.55% | ||
| TSHA - SPRY | 39% Loosely correlated | +8.84% | ||
| RYTM - SPRY | 36% Loosely correlated | +2.39% | ||
| KROS - SPRY | 35% Loosely correlated | +3.75% | ||
More | ||||